Results 101 to 110 of about 389,571 (303)
Autism Research, EarlyView.ABSTRACT Autism spectrum disorder (ASD) is associated with differences in neurodevelopment and altered metabolism, yet the interplay between brain morphometry, mitochondrial and energy metabolism biomarkers, and autistic traits in adults remains poorly understood. This study investigates the link between brain structure, psychometric measures, and both
Eleonora Esposto +10 more
wiley +1 more source
Frontiers in PsychiatryBackgroundPsychotic disorders are characterized by white matter (WM) abnormalities; however, their relationship with the various aspects of illness presentation remains unclear.
Umit Haluk Yesilkaya +13 more
doaj +1 more source
Rethinking schizophrenia [PDF]
Nature, 2010 How will we view schizophrenia in 2030? Schizophrenia today is a chronic, frequently disabling mental disorder that affects about one per cent of the world's population. After a century of studying schizophrenia, the cause of the disorder remains unknown. Treatments, especially pharmacological treatments, have been in wide use for nearly half a century,
openaire +2 more sources
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Ethical Issues in Delivering Psychological Therapies in Geriatric Psychiatry in India
Indian Journal of Psychological Medicine, 2021 Sridhar Vaitheswaran +7 more
doaj +1 more source
Immunology of Schizophrenia [PDF]
Neuroimmunomodulation, 2014 Increased proinflammatory markers like cytokines have been described in the blood and cerebrospinal fluid of patients suffering from schizophrenia. Animal models have shown that a hit in early life to the immune system might trigger a lifelong increased immune reactivity.
openaire +3 more sources
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen +4 more
wiley +1 more source
Exploring new avenues: Psychedelic‐assisted therapy for young people
British Journal of Clinical Pharmacology, EarlyView.Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou +3 more
wiley +1 more source
Comparison of memory writing style in patients with disorders, schizophrenia,schizoaffective and bipolar mood [PDF]
Introduction: Mental disorders difficultly are detected because not associated with physical defects. When disorders have signs and symptoms are very similar, the problem is much. The main goal of this study was survey of comparison of memory writing
شیخ اکبری, فرشاد +4 more
core
Schizophrenia and Bipolar Disorder in Urban Areas
, 2007 Background Earlier studies have shown that schizophrenic patients are more likely to be living in densely populated inner city areas, whereas bipolar patients are more widely distributed.
Cooke, Angela +5 more
core +1 more source